Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Investigator, Hepion
ASCEND, NCT05402371 / 2021-005185-18: A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis	Active, not recruiting	2	120	Europe, US, RoW	Rencofilstat, CRV431, Placebo	Hepion Pharmaceuticals, Inc., Hepion Pharmaceuticals, Inc.	Nonalcoholic Steatohepatitis (NASH), Fibrosis, Liver, NAFLD	05/25	09/25